Kenvue Inc. $KVUE Stake Decreased by Victory Capital Management Inc.

Victory Capital Management Inc. cut its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 4.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,509,576 shares of the company’s stock after selling 106,668 shares during the period. Victory Capital Management Inc.’s holdings in Kenvue were worth $40,730,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in KVUE. Salomon & Ludwin LLC bought a new stake in Kenvue during the 3rd quarter valued at $25,000. NBT Bank N A NY increased its holdings in shares of Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after purchasing an additional 1,006 shares during the period. Cornerstone Planning Group LLC increased its holdings in shares of Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after purchasing an additional 1,361 shares during the period. Golden State Wealth Management LLC raised its stake in shares of Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in shares of Kenvue by 50.9% during the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Canaccord Genuity Group increased their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday, February 18th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and dropped their price target for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Citigroup upped their price target on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 18th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Finally, UBS Group raised their price objective on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $19.58.

Insider Activity at Kenvue

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were acquired at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 1.68% of the stock is owned by insiders.

Kenvue Trading Up 0.9%

Shares of KVUE stock opened at $18.41 on Friday. The stock has a 50-day simple moving average of $17.85 and a 200 day simple moving average of $17.43. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The stock has a market capitalization of $35.29 billion, a P/E ratio of 23.91, a P/E/G ratio of 4.21 and a beta of 0.51. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same period in the previous year, the company earned $0.26 earnings per share. Kenvue’s revenue was up 3.2% compared to the same quarter last year. On average, sell-side analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 annualized dividend and a dividend yield of 4.5%. Kenvue’s payout ratio is currently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.